Monday, February 24, 2025

Top 5 This Week

Genetic testing giant 23andMe cuts 40% of workforce, discontinues therapeutics division – Press Enterprise




The restructuring arrives during a period of turmoil at the company that has included a high-profile data breach and several rounds of previous layoffs.

Subscribe to continue reading this article.
Already subscribed? To login in, click here.

Originally Published: November 12, 2024 at 3:19 PM PST

Related Posts

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles